cancer
Every record this desk has filed under cancer, newest first, each with the number of sources it can still show you.
FDA grants accelerated approval for a head and neck cancer treatment for some adults
The FDA granted accelerated approval to Rybrevant Faspro for adults with recurrent or metastatic head and neck squamous cell carcinoma whose disease progressed on or after specified treatments. The agency says long-term clinical benefit is not yet confirmed and has required confirmatory studies. An HPV-associated oropharyngeal cancer is excluded from the indication.
Also filed underhealthfdadrug-approvalpatient-care
A record appears here because it carries cancer in its own tags. If a record you expected is missing, it was filed under a different subject — the full list is on the topics index.